{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,19]],"date-time":"2026-11-19T06:28:29Z","timestamp":1795069709708,"version":"4.10.2"},"reference-count":25,"publisher":"Oxford University Press (OUP)","issue":"8","license":[{"start":{"date-parts":[[2021,7,17]],"date-time":"2021-07-17T00:00:00Z","timestamp":1626480000000},"content-version":"vor","delay-in-days":1,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2022,4,28]]},"abstract":"<jats:title>Abstract<\/jats:title>\n               <jats:sec>\n                  <jats:title>Background<\/jats:title>\n                  <jats:p>Staphylococcus aureus bacteremia (SAB) is in 10% to 20% of cases complicated by infective endocarditis. Clinical prediction scores may select patients with SAB at highest risk for endocarditis, improving the diagnostic process of endocarditis. We compared the accuracy of the Prediction Of Staphylococcus aureus Infective endocarditiseTime to positivity, Iv drug use, Vascular phenomena, preExisting heart condition (POSITIVE), Predicting Risk of Endocarditis Using a Clinical Tool (PREDICT), and VIRSTA scores for classifying the likelihood of endocarditis in patients with SAB.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Methods<\/jats:title>\n                  <jats:p>Between August 2017 and September 2019, we enrolled consecutive adult patients with SAB in a prospective cohort study in 7 hospitals in the Netherlands. Using the modified Duke Criteria for definite endocarditis as reference standard, sensitivity, specificity, negative predictive (NPV), and positive predictive values were determined for the POSITIVE, PREDICT, and VIRSTA scores. An NPV of at least 98% was considered safe for excluding endocarditis.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Results<\/jats:title>\n                  <jats:p>Of 477 SAB patients enrolled, 33% had community-acquired SAB, 8% had a prosthetic valve, and 11% a cardiac implantable electronic device. Echocardiography was performed in 87% of patients, and 42% received transesophageal echocardiography (TEE). Eighty-seven (18.2%) had definite endocarditis. Sensitivity was 77.6% (65.8%\u201386.9%), 85.1% (75.8%\u201391.8%), and 98.9% (95.7%\u2013100%) for the POSITIVE (n = 362), PREDICT, and VIRSTA scores, respectively. NPVs were 92.5% (87.9%\u201395.8%), 94.5% (90.7%\u201397.0%), and 99.3% (94.9%\u2013100%). For the POSITIVE, PREDICT, and VIRSTA scores, 44.5%, 50.7%, and 70.9% of patients with SAB, respectively, were classified as at high risk for endocarditis.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Conclusions<\/jats:title>\n                  <jats:p>Only the VIRSTA score had an NPV of at least 98%, but at the expense of a high number of patients classified as high risk and thus requiring TEE.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Clinical Trials Registration<\/jats:title>\n                  <jats:p>Netherlands Trial Register code 6669.<\/jats:p>\n               <\/jats:sec>","DOI":"10.1093\/cid\/ciab632","type":"journal-article","created":{"date-parts":[[2021,7,13]],"date-time":"2021-07-13T19:10:50Z","timestamp":1626203450000},"page":"1442-1449","source":"Crossref","is-referenced-by-count":54,"title":["Prediction Rules for Ruling Out Endocarditis in Patients With <i>Staphylococcus aureus<\/i> Bacteremia"],"prefix":"10.1093","volume":"74","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-5873-0474","authenticated-orcid":false,"given":"Thomas W","family":"van der Vaart","sequence":"first","affiliation":[{"name":"Julius Center for Health Sciences and Primary Care, University Medical Center Utrecht, Utrecht University, Utrecht, The Netherlands"},{"name":"Department of Internal Medicine, Division of Infectious Diseases, Amsterdam UMC, University of Amsterdam, Amsterdam, The Netherlands"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jan M","family":"Prins","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine, Division of Infectious Diseases, Amsterdam UMC, University of Amsterdam, Amsterdam, The Netherlands"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robin","family":"Soetekouw","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine, Spaarne Gasthuis, Haarlem, The Netherlands"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gitte","family":"van Twillert","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine, Noordwest Ziekenhuisgroep, Alkmaar, The Netherlands"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jan","family":"Veenstra","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine, OLVG, Amsterdam, The Netherlands"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bjorn L","family":"Herpers","sequence":"additional","affiliation":[{"name":"Department of Medical Microbiology, Spaarne Gasthuis, Haarlem, The Netherlands"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wouter","family":"Rozemeijer","sequence":"additional","affiliation":[{"name":"Department of Medical Microbiology, Noordwest Ziekenhuisgroep, Alkmaar, The Netherlands"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rogier R","family":"Jansen","sequence":"additional","affiliation":[{"name":"Department of Medical Microbiology, OLVG, Amsterdam, The Netherlands"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marc J M","family":"Bonten","sequence":"additional","affiliation":[{"name":"Julius Center for Health Sciences and Primary Care, University Medical Center Utrecht, Utrecht University, Utrecht, The Netherlands"},{"name":"Department of Medical Microbiology, University Medical Center Utrecht, Utrecht University, Utrecht, The Netherlands"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jan T M","family":"van der Meer","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine, Division of Infectious Diseases, Amsterdam UMC, University of Amsterdam, Amsterdam, The Netherlands"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2021,7,16]]},"reference":[{"key":"2022042816591494500_CIT0001","doi-asserted-by":"crossref","first-page":"e73096","DOI":"10.1371\/journal.pone.0073096","article-title":"Low incidence of livestock-associated methicillin-resistant Staphylococcus aureus bacteraemia in The Netherlands in 2009","volume":"8","author":"van Cleef","year":"2013","journal-title":"PloS One"},{"key":"2022042816591494500_CIT0002","doi-asserted-by":"crossref","first-page":"1072","DOI":"10.1016\/S0735-1097(97)00250-7","article-title":"Role of echocardiography in evaluation of patients with Staphylococcus aureus bacteremia: experience in 103 patients","volume":"30","author":"Fowler","year":"1997","journal-title":"J Am Coll Cardiol"},{"key":"2022042816591494500_CIT0003","doi-asserted-by":"crossref","first-page":"414","DOI":"10.1093\/ejechocard\/jer023","article-title":"Prevalence of infective endocarditis in patients with Staphylococcus aureus bacteraemia: the value of screening with echocardiography","volume":"12","author":"Rasmussen","year":"2011","journal-title":"Eur J Echocardiogr"},{"key":"2022042816591494500_CIT0004","doi-asserted-by":"crossref","first-page":"e0127385","DOI":"10.1371\/journal.pone.0127385","article-title":"Staphylococcus aureus Bloodstream Infection and Endocarditis\u2013a Prospective Cohort Study","volume":"10","author":"Le Moing","year":"2015","journal-title":"PLoS One"},{"key":"2022042816591494500_CIT0005","doi-asserted-by":"crossref","first-page":"871","DOI":"10.1111\/echo.12173","article-title":"The diagnostic utility of transthoracic echocardiography for the diagnosis of infective endocarditis in the real world of the Italian Registry on Infective Endocarditis","volume":"30","author":"Cecchi","year":"2013","journal-title":"Echocardiography"},{"key":"2022042816591494500_CIT0006","doi-asserted-by":"crossref","first-page":"900","DOI":"10.1016\/j.cmi.2017.04.025","article-title":"Clinical predictors and clinical prediction rules to estimate initial patient risk for infective endocarditis in Staphylococcus aureus bacteraemia: a systematic review and meta-analysis","volume":"23","author":"Bai","year":"2017","journal-title":"Clin Microbiol Infect"},{"key":"2022042816591494500_CIT0007","doi-asserted-by":"crossref","first-page":"224","DOI":"10.1046\/j.1445-5994.2001.00205.x","article-title":"Evaluation of clinical guidelines for the management of Staphylococcus aureus bacteraemia","volume":"32","author":"Blyth","year":"2002","journal-title":"Intern Med J"},{"key":"2022042816591494500_CIT0008","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1093\/cid\/civ235","article-title":"Predicting Risk of Endocarditis Using a Clinical Tool (PREDICT): scoring system to guide use of echocardiography in the management of Staphylococcus aureus bacteremia","volume":"61","author":"Palraj","year":"2015","journal-title":"Clin Infect Dis"},{"key":"2022042816591494500_CIT0009","doi-asserted-by":"crossref","first-page":"544","DOI":"10.1016\/j.jinf.2016.02.003","article-title":"The VIRSTA score, a prediction score to estimate risk of infective endocarditis and determine priority for echocardiography in patients with Staphylococcus aureus bacteremia","volume":"72","author":"Tubiana","year":"2016","journal-title":"J Infect"},{"key":"2022042816591494500_CIT0010","article-title":"T","author":"Kahn","year":"2020","journal-title":"Clin Microbiol Infect"},{"key":"2022042816591494500_CIT0011","doi-asserted-by":"crossref","DOI":"10.1093\/cid\/ciaa1844","article-title":"Validation of VIRSTA and PREDICT scores to determine the priority of echocardiography in patients with Staphylococcus aureus bacteremia","volume":"73","author":"Peinado-Acevedo","year":"2021","journal-title":"Clin Infect Dis"},{"key":"2022042816591494500_CIT0012","doi-asserted-by":"crossref","DOI":"10.1016\/j.cmi.2021.02.016","article-title":"Relationship between time-to-Positivity and infective endocarditis in patients with Staphylococcus aureus bacteremia","author":"Fida","year":"2021","journal-title":"Clin Microbiol Infect"},{"key":"2022042816591494500_CIT0013","doi-asserted-by":"crossref","first-page":"h5527","DOI":"10.1136\/bmj.h5527","article-title":"STARD 2015: an updated list of essential items for reporting diagnostic accuracy studies","volume":"351","author":"Bossuyt","year":"2015","journal-title":"BMJ"},{"key":"2022042816591494500_CIT0014","doi-asserted-by":"crossref","first-page":"1250","DOI":"10.1097\/01.CCM.0000050454.01978.3B","article-title":"2001 SCCM\/ESICM\/ACCP\/ATS\/SIS International Sepsis Definitions Conference","volume":"31","author":"Levy","year":"2003","journal-title":"Crit Care Med"},{"key":"2022042816591494500_CIT0015","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1016\/0021-9681(87)90171-8","article-title":"A new method of classifying prognostic comorbidity in longitudinal studies: development and validation","volume":"40","author":"Charlson","year":"1987","journal-title":"J Chronic Dis"},{"key":"2022042816591494500_CIT0016","first-page":"845","article-title":"Gram negative bacteremia: I. Etiology and ecology","author":"McCabe","year":"1962","journal-title":"Arch Intern Med"},{"key":"2022042816591494500_CIT0017","doi-asserted-by":"crossref","first-page":"633","DOI":"10.1086\/313753","article-title":"Proposed modifications to the Duke criteria for the diagnosis of infective endocarditis","volume":"30","author":"Li","year":"2000","journal-title":"Clin Infect Dis"},{"key":"2022042816591494500_CIT0018","first-page":"ciaa844","article-title":"Prospective validation of PREDICT and its impact on the transesophageal echocardiography use in management of Staphylococcus aureus bacteremia","author":"Abu Saleh","year":"2020","journal-title":"Clin Infect Dis"},{"key":"2022042816591494500_CIT0019","doi-asserted-by":"crossref","first-page":"1409","DOI":"10.1016\/S1473-3099(20)30447-3","article-title":"Defining persistent Staphylococcus aureus bacteraemia: secondary analysis of a prospective cohort study","volume":"20","author":"Kuehl","year":"2020","journal-title":"Lancet Infect Dis"},{"key":"2022042816591494500_CIT0020","doi-asserted-by":"crossref","first-page":"683","DOI":"10.1136\/heartjnl-2011-301246","article-title":"Risk prediction models: I. Development, internal validation, and assessing the incremental value of a new (bio)marker","volume":"98","author":"Moons","year":"2012","journal-title":"Heart"},{"key":"2022042816591494500_CIT0021","doi-asserted-by":"crossref","first-page":"476","DOI":"10.1177\/2048872617735809","article-title":"Risk assessment for infected endocarditis in Staphylococcus aureus bacteremia patients: when is transesophageal echocardiography needed?","volume":"8","author":"Longobardo","year":"2019","journal-title":"Eur Heart J Acute Cardiovasc Care"},{"key":"2022042816591494500_CIT0022","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1016\/j.cmi.2018.07.015","article-title":"Time to blood culture positivity: an independent predictor of infective endocarditis and mortality in patients with Staphylococcus aureus bacteraemia","volume":"25","author":"Sim\u00e9on","year":"2019","journal-title":"Clin Microbiol Infect"},{"key":"2022042816591494500_CIT0023","doi-asserted-by":"crossref","first-page":"594","DOI":"10.1086\/432472","article-title":"Time to positivity in Staphylococcus aureus bacteremia: possible correlation with the source and outcome of infection","volume":"41","author":"Khatib","year":"2005","journal-title":"Clin Infect Dis"},{"key":"2022042816591494500_CIT0024","doi-asserted-by":"crossref","first-page":"1187","DOI":"10.1007\/s10096-018-3239-1","article-title":"Increased overall survival after introduction of structured bedside consultation in Staphylococcus aureus bacteraemia","volume":"37","author":"Ariaans","year":"2018","journal-title":"Eur J Clin Microbiol Infect Dis"},{"key":"2022042816591494500_CIT0025","doi-asserted-by":"crossref","first-page":"1448","DOI":"10.1086\/516156","article-title":"Prevention of bacterial endocarditis: recommendations by the American Heart Association","volume":"25","author":"Dajani","year":"1997","journal-title":"Clin Infect Dis"}],"container-title":["Clinical Infectious Diseases"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/academic.oup.com\/cid\/advance-article-pdf\/doi\/10.1093\/cid\/ciab632\/39650155\/ciab632.pdf","content-type":"application\/pdf","content-version":"am","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/cid\/article-pdf\/74\/8\/1442\/43493217\/ciab632.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/cid\/article-pdf\/74\/8\/1442\/43493217\/ciab632.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,4,28]],"date-time":"2022-04-28T18:29:04Z","timestamp":1651170544000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/cid\/article\/74\/8\/1442\/6323152"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,7,16]]},"references-count":25,"journal-issue":{"issue":"8","published-online":{"date-parts":[[2021,7,16]]},"published-print":{"date-parts":[[2022,4,28]]}},"URL":"https:\/\/doi.org\/10.1093\/cid\/ciab632","relation":{},"ISSN":["1058-4838","1537-6591"],"issn-type":[{"value":"1058-4838","type":"print"},{"value":"1537-6591","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2022,4,15]]},"published":{"date-parts":[[2021,7,16]]}}}